Corporate Board Profile
Tech Score: 100/100
1 mention(s) identify VUONG TRIEU as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| Oncotelic Therapeutics, Inc. | 2020-06-25 | Dr. Trieu is the Chief Executive Officer of Autotelic, Inc. and in that capacity has the sole authority to control the voting and the disposition of Common Stock and Preferred Stock owned by Autotelic, Inc. Dr. Trieu disclaims beneficial ownership of the shares held by Autotelic, Inc., except to the extent of his pecuniary interest therein. | Vuong Trieu is the Chief Executive Officer of Autotelic, Inc., a company mentioned in the filing, and has a Ph.D. indicating a technical background. He is also involved in the development of AI and Blockchain Driven Vision Systems through EdgePoint AI, suggesting technical expertise relevant to software and programming. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-06-25 | Dr. Trieu is the Chief Executive Officer of Autotelic, Inc. and in that capacity has the sole authority to control the voting and the disposition of Common Stock and Preferred Stock owned by Autotelic, Inc. Dr. Trieu disclaims beneficial ownership of the shares held by Autotelic, Inc., except to the extent of his pecuniary interest therein. |
Data sourced from SEC filings. Last updated: 2025-10-11